content: <?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <headerData>
  <submissionType>144</submissionType>
  <filerInfo>
  <filer>
  <filerCredentials>
  <cik>0001716729</cik>
  <ccc>XXXXXXXX</ccc>
  </filerCredentials>
  </filer>
  <liveTestFlag>LIVE</liveTestFlag>
  </filerInfo>
  </headerData>
  <formData>
  <issuerInfo>
  <issuerCik>0001635088</issuerCik>
  <issuerName>Roivant Sciences Ltd.</issuerName>
  <secFileNumber>001-40782</secFileNumber>
  <issuerAddress>
  <street1 xmlns="http://www.sec.gov/edgar/common">7th Floor								</street1>
  <street2 xmlns="http://www.sec.gov/edgar/common">50 Broadway								</street2>
  <city xmlns="http://www.sec.gov/edgar/common">London</city>
  <stateOrCountry xmlns="http://www.sec.gov/edgar/common">X0</stateOrCountry>
  <zipCode xmlns="http://www.sec.gov/edgar/common">SW1H 0DB		</zipCode>
  </issuerAddress>
  <issuerContactPhone>44-207-400-3347</issuerContactPhone>
  <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>SVF Investments (UK) Limited</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
  <relationshipsToIssuer>
  <relationshipToIssuer>Stockholder</relationshipToIssuer>
  </relationshipsToIssuer>
  </issuerInfo>
  <securitiesInformation>
  <securitiesClassTitle>Common shares, par value $0.0000000341740141</securitiesClassTitle>
  <brokerOrMarketmakerDetails>
  <name>J.P. Morgan Securities LLC</name>
  <address>
  <street1 xmlns="http://www.sec.gov/edgar/common">383 Madison Avenue</street1>
  <city xmlns="http://www.sec.gov/edgar/common">New York</city>
  <stateOrCountry xmlns="http://www.sec.gov/edgar/common">NY</stateOrCountry>
  <zipCode xmlns="http://www.sec.gov/edgar/common">10179</zipCode>
  </address>
  </brokerOrMarketmakerDetails>
  <noOfUnitsSold>10000000</noOfUnitsSold>
  <aggregateMarketValue>131900000</aggregateMarketValue>
  <noOfUnitsOutstanding>771742197</noOfUnitsOutstanding>
  <approxSaleDate>09/28/2023</approxSaleDate>
  <securitiesExchangeName>Nasdaq</securitiesExchangeName>
  </securitiesInformation>
  <securitiesToBeSold>
  <securitiesClassTitle>Common shares, par value $0.0000000341740141</securitiesClassTitle>
  <acquiredDate>12/31/2018</acquiredDate>
  <natureOfAcquisitionTransaction>Acquired in multiple transactions from August 2017 to December 2018.</natureOfAcquisitionTransaction>
  <nameOfPersonfromWhomAcquired>Issuer</nameOfPersonfromWhomAcquired>
  <isGiftTransaction>N</isGiftTransaction>
  <amountOfSecuritiesAcquired>99375586</amountOfSecuritiesAcquired>
  <paymentDate>12/31/2018</paymentDate>
  <natureOfPayment>Cash</natureOfPayment>
  </securitiesToBeSold>
  <nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>
  <noticeSignature>
  <noticeDate>09/28/2023</noticeDate>
  <signature>SVF Investments (UK) Limited, By: /s/ Amanda Sanchez-Barry, General Counsel of SB Investment Advisers (UK) Limited</signature>
  </noticeSignature>
  </formData>
  </edgarSubmission>
metadata_documents: [{"type": "144", "sequence": "1", "filename": "primary_doc.xml", "secsgml_size_bytes": 2967}]
text: 144
  0001716729
  XXXXXXXX
  LIVE
  0001635088
  Roivant Sciences Ltd.
  001-40782
  7th Floor
  50 Broadway
  London
  X0
  SW1H 0DB
  44-207-400-3347
  SVF Investments (UK) Limited
  Stockholder
  Common shares, par value $0.0000000341740141
  J.P. Morgan Securities LLC
  383 Madison Avenue
  New York
  NY
  10179
  10000000
  131900000
  771742197
  09/28/2023
  Nasdaq
  Common shares, par value $0.0000000341740141
  12/31/2018
  Acquired in multiple transactions from August 2017 to December 2018.
  Issuer
  N
  99375586
  12/31/2018
  Cash
  Y
  09/28/2023
  SVF Investments (UK) Limited, By: /s/ Amanda Sanchez-Barry, General Counsel of SB Investment Advisers (UK) Limited